Venture Capital Archives - Page 7 of 112 - Boston Life Sciences Times

Iterative Health Raises $77 Million to Expand Clinical Research Network

April 30, 2026

Thermo Fisher Opens Bioprocess Design Center in Massachusetts to Speed Biologics Development

April 28, 2026

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

April 27, 2026

THIS WEEK'S STORIES

VectorY Therapeutics Cleared to Expand ALS Clinical Trial to Europe and U.K.

April 28, 2026

AstraZeneca’s SAPHNELO Approved in U.S. as Self-Injectable Treatment for Lupus

April 27, 2026

PCI Pharma Services Unveils $1 Billion Expansion to Boost U.S. Drug Manufacturing Capabilities

April 27, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Venture Capital

Moleculent Raises $20 Million to Expand Functional Profiling Platform

AcuityMD raises $80 million to expand AI platform for medical device industry

Orthogon Therapeutics Secures $11 Million to Advance BK Virus Antiviral Program

Alloy Therapeutics Raises $40 Million, Reaches $1 Billion Valuation to Expand AI-Driven Drug Development Platform

Jeito Capital Leads $75 Million Funding Round to Advance Adcendo Cancer Drug Pipeline

Most Read

Merck KGaA Doses First Patient in Phase 3 Lupus Skin Study

Johnson & Johnson Names Ryan Koors Vice President of Investor Relations

Moleculent Raises $20 Million to Expand Functional Profiling Platform

Komodo Health Names Paul Thomas Chief Financial Officer

EDITOR PICKS

Iterative Health Raises $77 Million to Expand Clinical Research Network

Thermo Fisher Opens Bioprocess Design Center in Massachusetts to Speed Biologics Development

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

THIS WEEK'S STORIES

VectorY Therapeutics Cleared to Expand ALS Clinical Trial to Europe and U.K.

AstraZeneca’s SAPHNELO Approved in U.S. as Self-Injectable Treatment for Lupus

PCI Pharma Services Unveils $1 Billion Expansion to Boost U.S. Drug Manufacturing Capabilities

POPULAR CATEGORY

ABOUT US

FOLLOW US